Many studies demonstrate that SIRT1 exhibits anti-inflammatory properties in vitro and in vivo as well as in clinical studies (e.g., patients with COPD) [37,73,98–104]. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.